H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: Functional characterization

Oncogene

Volumn 23, Issue 1, 2004, Pages 109-121

  Celetti, Angela ^a   Cerrato, Aniello ^a   Merolla, Francesco ^a   Vitagliano, Donata ^a   Vecchio, Giancarlo ^a   Grieco, Michele ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Apoptosis; Carcinogenesis; ERK; H4(D10S170); RET PTC1; Stress; Thyroid; TUNEL

Indexed keywords

GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROTECTION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE FUSION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; THYROID CARCINOMA; THYROID FOLLICLE CELL;

ANIMALS; APOPTOSIS; CARCINOMA, PAPILLARY; GENE REARRANGEMENT; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; ONCOGENE PROTEINS, FUSION; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RABBITS; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0942290418     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206981     Document Type: Article

References (39)

1. Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A, Marshall CJ and Cowley S. (1994). EMBO J., 13, 1610-1619.
2. Baron U and Bujard H. (2000). Methods Enzymol., 327, 401-421.
3. Bouillet P and Strasser A. (2002). J. Cell. Sci., 115, 1567-1574.
4. Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M and Suarez HG. (1997a). Oncogene, 15, 1263-1273.
5. Bounacer A, Wicker R, Schlumberger M, Sarasin A and Suarez HG. (1997b). Biochimie, 79, 619-623.
6. Butt AJ, Firth SM, King MA and Baxter RC. (2000). J. Biol. Chem., 275, 39174-39181.
7. Castellone MD, Cirafici AM, Vita GD, Falco VD, Malorni L, Tallini G, Fagin JA, Fusco A, Melillo RM and Santoro M. (2003). Oncogene, 22, 246-255.
8. Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G and Vecchio G. (1987). Nature, 328, 170-172.
9. Graham FL and van der Eb. (1973). Virology, 54, 536-539.
10. Grieco M, Cerrato A, Santoro M, Fusco A, Melillo RM and Vecchio G. (1994). Oncogene, 9, 2531-2535.
11. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A and Vecchio G. (1990). Cell, 60, 557-563.
12. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N and Akiyama M. (1993). Cancer Res., 53, 2940-2943.
13. Jhiang SM. (2000). Oncogene, 19, 5590-5597.
14. Jossart GH, O'Brien B, Cheng JF, Tong Q, Jhiang SM, Duh Q, Clark OH and Weier HU. (1996). Cytogenet. Cell Gene, 75, 254-257.
15. Kulkarni S, Heath C, Parker S, Chase A, Iqbal S, Pocock CF, Kaeda J, Cwynarski K, Goldman JM and Cross NC. (2000). Cancer Res., 60, 3592-3598.
16. Laemli UK. (1970). Nature, 227, 680-685.
17. Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J and Lax I. (2001). Mol. Cell. Biol., 21, 4177-4187.
18. Mitchell KO, Ricci MS, Mivashita T, Dicker DT, Jin Z, Reed JC and El-Deiry WS. (2000). Cancer Res., 60, 6318-6325.
19. Mizuno T, Iwamoto KS, Kyoizumi S, Nagamura H, Shinohara T, Koyama K, Seyama T and Hamatani K. (2000). Oncogene, 19, 438-443.
20. Moysich KB, Menezes RJ and Michalek AM. (2002). Lancet Oncol., 3, 527-528.
21. Nikiforova MN, Stringer JR, Blough R, Medvedovic M, Fagin JA and Nikiforov YE. (2000). Science, 290, 138-141.
22. Pierotti MA. (2001). Cancer Lett., 166, 1-7.
23. Pierotti MA, Santoro M, Jenkins RB, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo A, Herrmann MA, Fusco A, Vecchio G and Della Porta G. (1992). Proc. Natl. Acad. Sci. USA, 89, 1616-1620.
24. Portella G, Salvatore D, Botti G, Cerrato A, Zhang L, Mineo A, Chiappetta G, Santelli G, Pozzi L, Vecchio G, Fusco A and Santoro M. (1996). Oncogene, 13, 2021-2026.
25. Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D and Klugbauer S. (2000). Clin. Cancer Res., 6, 1093-1103.
26. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y and Hakomais S. (1996). Int. J. Cancer, 67, 101-105.
27. Salvatore D, Barone MV, Salvatore G, Melillo RM, Chiappetta G, Mineo A, Fenzi G, Vecchio G, Fusco A and Santoro M. (2000). J. Clin. Endocrinol. Metab., 85, 3898-3907.
28. Santoro M, Melillo RM, Carlomagno F, Fusco A and Vecchio G. (2002). Ann. NY Acad. Sci., 963, 116-121.
29. Santoro M, Wong WT, Aroca P, Santos E, Matoskova B, Grieco M, Fusco A and Di Fiore PP. (1994). Mol. Cell. Biol., 14, 663-675.
30. Schlumberger M, Cailleux AF, Suarez HG and de Vathaire F. (1999). CR Acad. Sci. III, 322, 205-213.
31. Schwaller J, Anastasiadou E, Cain D, Kutok J, Wojiski S, Williams IR, La Starza R, Crescenzi B, Sternberg DW, Andreasson P, Schiavo R, Siena S, Mecucci C and Gilliland DG. (2001). Blood, 97, 3910-3918.
32. Sheils OM, O'Leary JJ and Sweeney EC. (2000). J. Pathol., 192, 32-36.
33. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW and Ingram AJ. (2002). J. Biol. Chem., 277, 12710-12717.
34. Tong Q, Xing S and Jhiang SM. (1997). J. Biol. Chem., 272, 9043-9047.
35. Towbin H, Staehelin T and Gordon J. (1979). Proc. Natl. Acad. Sci. USA, 76, 4350-4354.
36. Tuttle RM and Becker DV. (2000). Semin. Nucl. Med., 30, 133-140.
37. Wang J, Knauf JA, Basu S, Puxeddu E, Kuroda H, Santoro M, Fusco A and Fagin JA. (2003). Mol. Endocrinol., 17, 1426-1430.
38. Viglietto G, Chiappetta G, Martinez Tello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M and Fusco A. (1995). Oncogene, 11, 1207-1210.
39. Zhan Q, Fan S, Bal I, Guillong C, Liebermann DA, O'Connor PM and Fornace Jr AJ. (1994). Oncogene, 9, 3743-3751.